ACTIVE

Oxurion

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-3,2 M €-1 524,8 %over 1 year
Revenue644,5 €-78,2 %over 1 year
Equity-12,2 M €-15,6 %over 1 year
Workforce7,3 ETP-13,1 %over 1 year

Identity

Source · BCE/KBO

Oxurion is a Public limited company incorporated in 2006. Its main activity is: Activities of head offices. Its registered office is in Leuven. It employs on average 7,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0881.620.924
Incorporation
30/05/2006
Legal form
Public limited company
Registered office
Gaston Geenslaan 1
3001 Leuven · FlandreSee on map
Contributed capital
87 156 461,00 €
Latest accounts
31/12/2025
Average workforce
7,3 ETP
Joint committees (2)
  • 200
  • 207
Contacts
3 public details availableLog in to view

Financials

Source · NBB, 31 filings

Trend over 17 financial years

20252024202320222021
Income statement
Revenue644,5 €3 k €262,6 k €595,4 k €1,1 M €
EBITDA-3,4 M €360,6 k €-1,1 M €-4,8 M €-1,4 M €
Operating result-3,4 M €340,9 k €-12,2 M €-22,8 M €-25,4 M €
Net result-3,2 M €-199,2 k €-13,4 M €-24,5 M €-36,7 M €
Balance sheet
Equity-12,2 M €-10,5 M €-12,2 M €-6,4 M €-1,4 M €
Total assets2,8 M €3,5 M €5,8 M €8,4 M €16,8 M €
Cash244,5 k €367,3 k €1,6 M €3,3 M €9,4 M €
Debts14,3 M €13,5 M €17,6 M €14,3 M €17,7 M €
Other
Workforce7,3 ETP8,4 ETP14,4 ETP26,7 ETP43,1 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 74 ended

Active mandates

Nelly Souleymane

Director · since 14 février 2025 · until 04 mai 2027

Active
Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 04 mai 2027

Active
James Hartmann

Director · since 28 décembre 2023 · until 04 mai 2027

Active
MARS SARL

Director · since 28 décembre 2023 · until 04 mai 2027

Represented by Pascal Ghoson

Active
Anat Loewenstein

Director · since 02 mai 2023 · until 13 janvier 2025

Active
Nathalie Laarakker

Director · since 02 mai 2023 · until 13 janvier 2025

Active

Ended mandates

Nelly Souleymane

Director · since 14 février 2025 · until 06 mai 2025

Ended
Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 07 mai 2024

Ended
James Hartmann

Director · since 28 décembre 2023 · until 07 mai 2024

Ended
MARS SARL

Director · since 28 décembre 2023 · until 07 mai 2024

Represented by Pascal Ghoson

Ended

Other companies at this address

Gaston Geenslaan 1 3001 Leuven
CompanyCBE no.
ALIGOS BELGIUM● Active
0702.969.886
Bio-Incubator Leuven● Active
0876.605.232
Community Building Arenberg● Active
1014.096.594
Creative Biolabs Belgium● Active
1028.942.544
DName-iT● Active
0506.754.823
Fisherman● Active
0804.287.079
Fishway● Active
0787.869.632
Formac Pharmaceuticals● Active
0892.914.395
IDA INTERNATIONAL● Active
1002.119.470
Lever Bio Belgium● Active
1039.455.958
Maatschap reMYND● Active
1019.655.090
miDiagnostics● Active
0641.984.602
PALEO● Active
0756.986.614
PARKEERGEBOUW● Active
1009.039.728
Pledge Therapeutics● Active
0726.743.301
Qmineral● Active
0837.633.897
Raya Therapeutic● Active
1003.128.171
ReGenesys● Active
0877.070.337
ReGenesys EU● Active
0544.577.301
reMYND● Active
0476.910.101

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202627/06/202518/06/202401/06/202308/06/202218/06/2021
General meeting01/06/202613/05/202516/05/202402/05/202303/05/202204/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 31 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202501/06/202630/06/2026DutchPDF
Full model31/12/202413/05/202527/06/2025DutchPDF
Consolidated accounts31/12/202413/05/202527/06/2025DutchPDF
Full model31/12/202316/05/202418/06/2024DutchPDF
Consolidated accounts31/12/202316/05/202418/06/2024DutchPDF
Full model31/12/202202/05/202301/06/2023DutchPDF
Consolidated accounts31/12/202202/05/202301/09/2023DutchPDF
Full model31/12/202103/05/202208/06/2022DutchPDF
Full model31/12/202004/05/202118/06/2021DutchPDF
Consolidated accounts31/12/202004/05/202118/06/2021DutchPDF
Full model31/12/201905/05/202027/05/2020DutchPDF
Consolidated accounts31/12/201905/05/202027/05/2020DutchPDF
Full model31/12/201807/05/201906/06/2019DutchPDF
Consolidated accounts31/12/201801/01/999907/06/2019DutchPDF
Full model31/12/201702/05/201828/05/2018DutchPDF
Consolidated accounts31/12/201702/05/201805/07/2018DutchPDF
Full model31/12/201602/05/201701/06/2017DutchPDF
Consolidated accounts31/12/201602/05/201704/07/2017DutchPDF
Full model31/12/201503/05/201601/06/2016DutchPDF
Consolidated accounts31/12/201503/05/201601/06/2016DutchPDF
Full model31/12/201405/05/201528/05/2015DutchPDF
Consolidated accounts31/12/201405/05/201503/06/2015DutchPDF
Full model31/12/201306/05/201404/06/2014DutchPDF
Consolidated accounts31/12/201306/05/201404/06/2014DutchPDF
Full model31/12/201207/05/201306/06/2013DutchPDF
Consolidated accounts31/12/201207/05/201329/08/2013DutchPDF
Full model31/12/201102/05/201219/07/2012DutchPDF
Full model31/12/201003/05/201130/06/2011DutchPDF
Full model31/12/200904/05/201020/05/2010DutchPDF
Full model31/12/200805/05/200904/06/2009DutchPDF
Full model31/12/200706/05/200819/06/2008DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 74 ended

Active mandates

Nelly Souleymane

Director · since 14 février 2025 · until 04 mai 2027

Active
Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 04 mai 2027

Active
James Hartmann

Director · since 28 décembre 2023 · until 04 mai 2027

Active
MARS SARL

Director · since 28 décembre 2023 · until 04 mai 2027

Represented by Pascal Ghoson

Active
Anat Loewenstein

Director · since 02 mai 2023 · until 13 janvier 2025

Active
Nathalie Laarakker

Director · since 02 mai 2023 · until 13 janvier 2025

Active

Ended mandates

Nelly Souleymane

Director · since 14 février 2025 · until 06 mai 2025

Ended
Charles Paris de Bollardière

Director · since 28 décembre 2023 · until 07 mai 2024

Ended
James Hartmann

Director · since 28 décembre 2023 · until 07 mai 2024

Ended
MARS SARL

Director · since 28 décembre 2023 · until 07 mai 2024

Represented by Pascal Ghoson

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares27/08/2026
    KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE,
    PDF
  • Capital / shares30/06/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Other15/05/2026
    DIVERSEN
    PDF
  • Capital / shares30/03/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares17/02/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Other26/01/2026
    DIVERSEN
    PDF
  • Capital / shares04/11/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Other30/09/2025
    DIVERSEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 27/05/2026
    augmentation_capital
  2. 16/03/2026
    augmentation_capital
  3. 14/01/2026
    augmentation_capital
  4. 2025
    Annual accounts 2025-3,2 M €↓
  5. 15/10/2025
    augmentation_capital
  6. 03/10/2025
    augmentation_capital
  7. 30/07/2025
    augmentation_capital
  8. 25/07/2025
    augmentation_capital
  9. 24/07/2025
    augmentation_capital
  10. 23/07/2025
    augmentation_capital
  11. 03/07/2025
    augmentation_capital
  12. 03/06/2025
    augmentation_capital
  13. 09/05/2025
    augmentation_capital
  14. 21/03/2025
    augmentation_capital
  15. 14/02/2025
    nominationNelly Souleymane — onafhankelijke niet-uitvoerende bestuurder
  16. 10/01/2025
    augmentation_capital
  17. 2024
    Annual accounts 2024-199,2 k €↑
  18. 30/12/2024
    augmentation_capital
  19. 04/12/2024
    augmentation_capital
  20. 08/10/2024
    augmentation_capital
  21. 23/09/2024
    augmentation_capital
  22. 03/09/2024
    autre
  23. 18/07/2024
    augmentation_capital
  24. 22/05/2024
    augmentation_capital
  25. 02/05/2024
    augmentation_capital
  26. 10/04/2024
    autre
  27. 25/03/2024
    augmentation_capital
  28. 20/03/2024
    augmentation_capital
  29. 29/02/2024
    augmentation_capital
  30. 14/02/2024
    augmentation_capital
  31. 2023
    Annual accounts 2023-13,4 M €↑
  32. 28/12/2023
    nominationCharles Paris de Bollardière — onafhankelijke niet-uitvoerende bestuurder
  33. 28/12/2023
    nominationJames Hartmann — onafhankelijke niet-uitvoerende bestuurder
  34. 28/12/2023
    nominationMARS SARL — Gedelegeerd Bestuurder
  35. 28/12/2023
    nominationAndy Deene — CDO
  36. 28/12/2023
    nominationPhilippe Barbeaux — CSO
  37. 06/07/2023
    augmentation_capital
  38. 27/06/2023
    augmentation_capital
  39. 12/05/2023
    augmentation_capital
  40. 09/05/2023
    augmentation_capital
  41. 05/05/2023
    augmentation_capital
  42. 02/05/2023
    augmentation_capital
  43. 25/04/2023
    augmentation_capital
  44. 05/04/2023
    augmentation_capital
  45. 28/03/2023
    augmentation_capital
  46. 22/03/2023
    augmentation_capital
  47. 2022
    Annual accounts 2022-24,5 M €↑
  48. 12/10/2022
    augmentation_capital
  49. 12/10/2022
    augmentation_capital
  50. 13/09/2022
    augmentation_capital
  51. 05/09/2022
    augmentation_capital
  52. 17/08/2022
    augmentation_capital
  53. 06/07/2022
    augmentation_capital
  54. 07/06/2022
    augmentation_capital
  55. 18/05/2022
    augmentation_capital
  56. 03/05/2022
    nominationPwC Bedrijfsrevisoren BV — commissaris
  57. 03/05/2022
    reconductionThomas Clay — onafhankelijk niet-uitvoerend bestuurder
  58. 03/05/2022
    reconductionMeRoNo BV — niet-uitvoerend bestuurder
  59. 03/05/2022
    reconductionDr. David Guyer — onafhankelijk niet-uitvoerend bestuurder
  60. 03/05/2022
    reconductionAdrienne Graves — onafhankelijk niet-uitvoerend bestuurder
  61. 03/05/2022
    reconductionThomas Graney — uitvoerend bestuurder
  62. 15/04/2022
    augmentation_capital
  63. 2021
    Annual accounts 2021-36,7 M €↓
  64. 2020
    Annual accounts 2020-26,9 M €↑
  65. 2019
    Annual accounts 2019-50,2 M €↓
  66. 2018
    Annual accounts 2018-36,9 M €↓
  67. 2018
    Name changeOxurion NV
  68. 2017
    Annual accounts 201723,8 M €↑
  69. 2016
    Annual accounts 2016-67,3 M €↓
  70. 2015
    Annual accounts 2015-29,4 M €↑
  71. 2014
    Annual accounts 2014-51,2 M €↓
  72. 2013
    Annual accounts 201314 M €↓
  73. 2012
    Annual accounts 201220,8 M €↑
  74. 2011
    Annual accounts 2011-31,5 M €↓
  75. 2010
    Annual accounts 2010-26,8 M €↓
  76. 2008
    Annual accounts 200814,1 M €
  77. 2008
    Name changeThromboGenics
  78. 30/05/2006
    IncorporationPublic limited company